We are pleased to announce that the Interdisciplinary Leukemia Project has launched a new "What's New in t-AML" feature on the project''s website.

This page features significant recent studies in therapy-related Acute Myeloid Leukemia.  Studies are organized into three main sections:  t-AML diagnosis and incidence, genetic abnormalities in t-AML, and t-AML treatment and outcomes.  Where possible, links to the primary publications are included. The page can be found at  https://t-aml.uchicago.edu/resources-publications/whats-new-in-t-aml/

The Interdisciplinary Leukemia Project is  a six-part systems biology-based interdisciplinary attack on therapy-based Acute Myeloid Leukemia, a secondary cancer that strikes 8 to 10% of cancer survivors. The five year program includes high-throughput genomic screening, work in blood stem cells, clinical trials and high-level informatics, all focused on the same disease and pursued at the same time in a coordinated manner. While the primary goal of this project is to find answers surrounding this terrible disease, the hope is that by applying a systems-based approach to cancer research, the project will be able to change the way that cancer science is pursued.

Learn more about the Interdisciplinary Leukemia Project

• Cancer & Science »
• Programs »
• Events »
• From the Executive Director »

The Cancer Research Foundation has focused attention on cancer and raised money for life-giving research. We...pay tribute to the scientists who have dedicated themselves to finding a cure and to meet the young researchers who are the next generation of fighters against this disease. The message we send today is that those who suffer from cancer are not alone and that together we can work toward a solution."